🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NIC-FTD in person meeting at the International Society for Frontotemporal Dementias conference! Great to finally meet everyone in real life. #ISFTD2022 #NICFTD

AFX Medical AFX Medical is excited to work with the McGill CLIC Centre at the Centre universitaire de santé McGill to develop our brain metastasis product: healthenews.mcgill.ca/mcgill-start-u…

Une paire d’yeux de plus pour les oncologues plus.lapresse.ca/screens/94e93a… via La Presse AFX Medical Centre de recherche du CHUM

Scientists spend too much time taking “professional selfies”. A paper from PNAS describes what it takes to be a scientist today. Key points (that I always emphasize myself): #AcademicTwitter Academic Chatter™ #research

Shafiei et al. show that atrophy patterns in sporadic & genetic bvFTD are jointly shaped by global connectome architecture and local transcriptomic vulnerability, helping explain how different pathological entities can lead to the same clinical syndrome. bit.ly/3R7xOKK

Help us spread the word & join us at the 33rd Annual ANPA Meeting. Simon Ducharme Valerie Voon Trey Bateman Schmahmann Lab Barbara Schildkrout Shan Siddiqi @shansiddiqi.bsky.social Michael Fox Selma Aybek Neuropsychiatry Nolan Williams Mia Minen, MD, MPH, FAAN, FAHS Matt Burke @PerezMGHLab & many others - RTs appreciated!

Our new website is LIVE: nic-ftd.com! Check out our working groups, output, news and much more! #NICFTD #endFTD

I am happy to share this new paper with practical practice recommendations for psychiatrists: Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry - The American Journal of Geriatric Psychiatry ajgponline.org/article/S1064-… NIC-FTD Douglas Research Centre

Researchers at several sites across Canada, led by Simon Ducharme, are conducting a study to see if a medication named nabilone, taken by mouth, can help reduce restlessness and agitation in people with FTD, including bvFTD and PPA. Click here to learn more: bit.ly/3UjKJNc

New paper on the Clinical Use of Dementia Biomarkers to Evaluate Cognitive Deficits in People With Primary Psychiatric Disorders. A complex area that requires more research Practical Neurology NIC-FTD Douglas Research Centre practicalneurology.com/articles/2024-…

Looking forward to start this important clinical trial

New study showing that serum neurofilament light chains levels are useful to differentiate frontotemporal dementia from primary psychiatric disorders, but accuracy decreases in older age ajgponline.org/article/S1064-…

Thank you to the ⁦The Neuro⁩ ⁦CRU MNI⁩ ⁦Passage Bio⁩ to make this innovative research treatment possible ici.radio-canada.ca/nouvelle/20689…

Dr. Simon Ducharme was recently invited to co-chair a session on imaging biomarkers at #ISFTD24. He is a neuropsychiatrist and PI for #dementia studies at The Neuro, including a groundbreaking gene therapy study for frontotemporal dementia: cbc.ca/player/play/vi…. #FTD #mcgill

Interesting new article on the “BvFTD-by-proxy” phenomenon, an unintended consequence of increased disease awareness tandfonline.com/doi/full/10.10…

The Center for Precision Psychiatry - Québec is releasing a first batch of open access data on its transdiagnostic SPARK cohort of deeply phenotyped patients with psychiatric disorders. Researchers can access data here: cppquebec.ca/data @fondation_hgm Fondation Douglas | Douglas Foundation

Thank you to the @fondation_hgm for their ongoing support to the Center for Precision Psychiatry - Québec: mghfoundation.com/news/centre-fo…

New article from NIC-FTD. The rate of misdiagnosis of primary psychiatric disorders among bvFTD patients remains high (13%), but it has decreased over time Douglas Research Centre psychiatryonline.org/doi/10.1176/ap…